Fundraising FoxCalidar
Durham, US · Founded 2022 · Delaware corporation
Find your way into Calidar
Sign up to see every warm intro you have to Calidar
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calidar team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Calidar develops X-ray diffraction imaging technology, including a patented 4D Mammography system that noninvasively maps X-ray scatter signatures in breast tissue to detect molecular-level markers of cancer. The technology aims to provide earlier and more accurate breast cancer diagnosis without biopsies, needles, or contrast injection.
Founders & leadership
JC
Joshua CarpenterNamed on SEC filing
SS
Stefan StrykerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$270.8K disclosed across 1 round · 2022
▶$270.8KraisedJan 2022 · 2 investors · Other Health CareRule 506(b)
▶$270.8KraisedJan 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua CarpenterExecutive Officer, Director
- Stefan StrykerExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $270.8K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Diagonal TherapeuticsDiagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases. Its DIAGONAL Product Engine uses computational and experimental methods to identify clustering antibodies across receptor classes, with a lead candidate (DIAG723) in a Phase 1/2 trial for Hereditary Hemorrhagic Telangiectasia.
CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
Companies working in the same space as Calidar.
Frequently asked questions
- What does Calidar do?
- Calidar develops X-ray diffraction imaging technology, including a patented 4D Mammography system that noninvasively maps X-ray scatter signatures in breast tissue to detect molecular-level markers of cancer. The technology aims to provide earlier and more accurate breast cancer diagnosis without biopsies, needles, or contrast injection.
- How much funding has Calidar raised?
- Calidar has disclosed $270.8K raised across 1 round.
- Where is Calidar headquartered?
- Calidar is headquartered in Durham, US.